Evidence map›Paper›PMID 34889982›Full record

ReviewApplied microbiology and biotechnology2022

Mucoromycota fungi as powerful cell factories for modern biorefinery.

Simona Dzurendova, Cristian Bolano Losada, Benjamin Xavier Dupuy-Galet, Kai Fjær, Volha Shapaval

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Caracterização taxonômica integrativa de comunidades bacterianas e fúngicas de tripas de cupins e areia de folhas.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Usage of the FungusPolymers · 2025
    Article
  12. Article
  13. Frontiers in microbiology · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Simona DzurendovaNorwegian University of Life Sciences, Faculty of Science and Technology, Droebakveien 31, 1430, Aas, Norway.
Cristian Bolano LosadaNorwegian University of Life Sciences, Faculty of Science and Technology, Droebakveien 31, 1430, Aas, Norway.
Benjamin Xavier Dupuy-GaletNorwegian University of Life Sciences, Faculty of Science and Technology, Droebakveien 31, 1430, Aas, Norway.
Kai FjærNorwegian University of Life Sciences, Faculty of Science and Technology, Droebakveien 31, 1430, Aas, Norway.
Volha ShapavalNorwegian University of Life Sciences, Faculty of Science and Technology, Droebakveien 31, 1430, Aas, Norway. volha.shapaval@nmbu.no.ORCID http://orcid.org/0000-0003-2674-1328
Norwegian University of Life Sciences · NO

Funding

norges forskningsråd 257622norges forskningsråd 301834/E50norges forskningsråd 302543/E40norges forskningsråd 305215norges forskningsråd 309220norges forskningsråd 309558norges forskningsråd 327114
6 · The paper itself

Abstract

Biorefinery employing fungi can be a strategy for valorizing low-cost rest materials, by-products and wastes into several valuable bioproducts through the fungal fermentation. Mucoromycota fungi are soil fungi with a highly versatile metabolic system that positions them as powerful microbial cell factories for biorefinery applications. Lipids, pigments, chitin/chitosan, polyphosphates, ethanol, organic acids and enzymes are main Mucoromycota products that can be refined from the fermentation process and applied in nutrition, chemical or biofuel industries. In addition, Mucoromycota biomass can be used as it is for specific purposes, such as feed. Mucoromycota fungi can be employed in developing co-production processes, whereby several intra- and extracellular products are simultaneously formed in a single fermentation process, and, thus, economic viability of the process can be improved. This mini review provides a comprehensive overview over the recent advances in the production of valuable metabolites by Mucoromycota fungi and fermentation strategies which could be potentially applied in the industrial biorefinery settings. KEY POINTS: • Biorefineries utilizing Mucoromycota fungi as production cell factories can provide a wide range of bioproducts. • Mucoromycota fungi are able to perform co-production of various metabolites in a single fermentation process. • Versatile metabolism of Mucoromycota allows valorization of a various low-cost substrates such as wastes and rest materials.

Indexed as

BiofuelsFungiBiomassFermentationLipidsBiofuelsLipidsBiorefineryChitosanCo-cultureEnzymesLipidsMucoromycota fungiPigmentsPolyphosphate

Identifiers

PMID34889982
OpenAlexW4200484437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.